On the public citation graph

Structure-Based Pharmacophore Design and Virtual Screening for Novel Angiotensin Converting Enzyme 2 Inhibitors

0 signed · 111 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/jcc.540160205openalex-snapshot

Poling: Promoting conformational variation

inferredcites →https://doi.org/10.1016/j.tips.2004.04.001openalex-snapshot

ACE2: from vasopeptidase to SARS virus receptor

inferredcites →https://doi.org/10.1016/j.tips.2004.04.004openalex-snapshot

S-Adenosylhomocysteine hydrolase as a target for intracellular adenosine action

inferredcites →https://doi.org/10.1016/s1359-6446(04)02939-3openalex-snapshot

Novel technologies for virtual screening

inferredcites →https://doi.org/10.1021/bi00644a014openalex-snapshot

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

inferredcites →https://doi.org/10.1021/bi00644a015openalex-snapshot

Angiotensin I converting enzyme from human plasma

inferredcites →https://doi.org/10.1021/ci0400011openalex-snapshot

The Discovery of Kv1.5 Blockers as a Case Study for the Application of Virtual Screening Approaches

inferredcites →https://doi.org/10.1021/ci049844iopenalex-snapshot

Influenza Virus Neuraminidase Inhibitors: Generation and Comparison of Structure-Based and Common Feature Pharmacophore Hypotheses and Their Application in Virtual Screening

inferredcites →https://doi.org/10.1021/ci049885eopenalex-snapshot

LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters

inferredcites →https://doi.org/10.1021/ja0277226openalex-snapshot

Substrate-Based Design of the First Class of Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors

inferredcites →https://doi.org/10.1021/jm049073+openalex-snapshot

Discovery of High-Affinity Ligands of σ1 Receptor, ERG2, and Emopamil Binding Protein by Pharmacophore Modeling and Virtual Screening

inferredcites →https://doi.org/10.1023/a:1016307520660openalex-snapshot

Q-fit: A probabilistic method for docking molecular fragments by sampling low energy conformational space

inferredcites →https://doi.org/10.1038/nature03197openalex-snapshot

Virtual screening of chemical libraries

inferredcites →https://doi.org/10.1038/nrd1227openalex-snapshot

Ace revisited: A new target for structure-based drug design

inferredcites →https://doi.org/10.1038/nrd1549openalex-snapshot

Docking and scoring in virtual screening for drug discovery: methods and applications

inferredcites →https://doi.org/10.1074/jbc.m002615200openalex-snapshot

A Human Homolog of Angiotensin-converting Enzyme

inferredcites →https://doi.org/10.1074/jbc.m200581200openalex-snapshot

Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase

inferredcites →https://doi.org/10.1074/jbc.m311191200openalex-snapshot

ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis

inferredcites →https://doi.org/10.2174/1568026023392940openalex-snapshot

History and Evolution of the Pharmacophore Concept in Computer-Aided Drug Design

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9781394249190.ch8openalex-snapshot

Pharmacophore Modeling in Drug Design

inferred← citeshttps://doi.org/10.1002/9783527673643.ch02openalex-snapshot

In Silico Prediction of Drug Side Effects

inferred← citeshttps://doi.org/10.1002/cmdc.200900314openalex-snapshot

Comparison of Structure‐ and Ligand‐Based Virtual Screening Protocols Considering Hit List Complementarity and Enrichment Factors

inferred← citeshttps://doi.org/10.1002/cplu.201700539openalex-snapshot

Computer‐Aided Design and Synthesis of 1‐{4‐[(3,4‐Dihydroxybenzylidene)amino]phenyl}‐5‐oxopyrrolidine‐3‐carboxylic Acid as an Nrf2 Enhancer

inferred← citeshttps://doi.org/10.1002/jcc.21347openalex-snapshot

Identification of small molecule aggregators from large compound libraries by support vector machines

inferred← citeshttps://doi.org/10.1002/path.2162openalex-snapshot

The emerging role of ACE2 in physiology and disease

inferred← citeshttps://doi.org/10.1007/5584_2020_584openalex-snapshot

Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology

inferred← citeshttps://doi.org/10.1007/7355_2009_3openalex-snapshot

Lead Discovery Using Virtual Screening

inferred← citeshttps://doi.org/10.1007/7653_2020_49openalex-snapshot

Computational Modeling of ACE2-Mediated Cell Entry Inhibitors for the Development of Drugs Against Coronaviruses

inferred← citeshttps://doi.org/10.1007/978-1-4614-1247-2_7openalex-snapshot

Medicinal Chemistry and Ligand Profiling for Evaluation of Promising Marine Bioactive Molecules

inferred← citeshttps://doi.org/10.1007/978-3-642-36260-6_2openalex-snapshot

angiotensin-converting enzyme 2 3.4.17.23

inferred← citeshttps://doi.org/10.1007/978-3-7643-8117-2_6openalex-snapshot

Virtual screening for the discovery of bioactive natural products

inferred← citeshttps://doi.org/10.1007/s00044-014-1158-yopenalex-snapshot

Ligand-based 3D pharmacophore design, virtual screening and molecular docking for novel p38 MAPK inhibitors

inferred← citeshttps://doi.org/10.1007/s00044-016-1578-yopenalex-snapshot

Binding mode of conformations and structure-based pharmacophore development for farnesyltransferase inhibitors

inferred← citeshttps://doi.org/10.1007/s00044-019-02330-8openalex-snapshot

Exploration of synthetic antioxidant flavonoid analogs as acetylcholinesterase inhibitors: an approach towards finding their quantitative structure–activity relationship

inferred← citeshttps://doi.org/10.1007/s00894-012-1536-7openalex-snapshot

Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches

inferred← citeshttps://doi.org/10.1007/s11224-019-01394-xopenalex-snapshot

Computational basis for the design of PLK-2 inhibitors

inferred← citeshttps://doi.org/10.1007/s12010-021-03718-2openalex-snapshot

Screening and Identification of Potential iNOS Inhibitors to Curtail Cervical Cancer Progression: an In Silico Drug Repurposing Approach

inferred← citeshttps://doi.org/10.1007/s40203-026-00637-0openalex-snapshot

Integrated molecular docking, toxicity prediction, and molecular dynamics simulations studies to identify potential antimalarial candidates targeting enoyl-acyl carrier protein reductase enzyme

inferred← citeshttps://doi.org/10.1016/b978-0-12-374194-3.00010-xopenalex-snapshot

In Silico Screening

inferred← citeshttps://doi.org/10.1016/b978-0-12-381274-2.00010-8openalex-snapshot

Binding Site Identification and Structure Determination of Protein–Ligand Complexes by NMR

inferred← citeshttps://doi.org/10.1016/b978-0-12-809633-8.20276-8openalex-snapshot

Pharmacophore Development

inferred← citeshttps://doi.org/10.1016/b978-0-12-817903-1.00011-5openalex-snapshot

Pharmacophore modeling and virtual screening for the discovery of biologically active natural products

inferred← citeshttps://doi.org/10.1016/b978-0-12-821748-1.00001-4openalex-snapshot

Impact of chemoinformatics approaches and tools on current chemical research

inferred← citeshttps://doi.org/10.1016/b978-0-443-15457-7.00005-8openalex-snapshot

Virtual screening and molecular docking for the identification of potential antibreast cancer agents targeting estrogen receptor

inferred← citeshttps://doi.org/10.1016/j.bbamem.2010.12.004openalex-snapshot

Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation

inferred← citeshttps://doi.org/10.1016/j.biosystems.2013.12.002openalex-snapshot

Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents

inferred← citeshttps://doi.org/10.1016/j.bmc.2013.05.031openalex-snapshot

Design, synthesis and evaluation of novel 2-hydroxypyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors

inferred← citeshttps://doi.org/10.1016/j.bmcl.2008.01.046openalex-snapshot

Thiol-based angiotensin-converting enzyme 2 inhibitors: P1′ modifications for the exploration of the S1′ subsite

inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.03.046openalex-snapshot

Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques

inferred← citeshttps://doi.org/10.1016/j.ddtec.2006.11.003openalex-snapshot

Integration of virtual and physical screening

inferred← citeshttps://doi.org/10.1016/j.ddtec.2010.10.004openalex-snapshot

‘Fuzziness’ in pharmacophore-based virtual screening and de novo design

inferred← citeshttps://doi.org/10.1016/j.ddtec.2010.11.006openalex-snapshot

3D pharmacophores as tools for activity profiling

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2021.09.146openalex-snapshot

Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.jmgm.2007.12.002openalex-snapshot

A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor

inferred← citeshttps://doi.org/10.1016/j.jmgm.2008.04.002openalex-snapshot

Modeling the binding modes of Kv1.5 potassium channel and blockers

inferred← citeshttps://doi.org/10.1016/j.peptides.2022.170766openalex-snapshot

Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation

inferred← citeshttps://doi.org/10.1016/j.sciaf.2025.e02634openalex-snapshot

Computational screening campaign reveal natural candidates as potential ASK1 inhibitors: Pharmacophore modeling, molecular docking, MMGBSA calculations, ADMET prediction, and molecular dynamics simulation studies

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00932openalex-snapshot

Discovery of a Dual Tubulin and Poly(ADP-Ribose) Polymerase-1 Inhibitor by Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, and Biological Evaluation

inferred← citeshttps://doi.org/10.1021/ci600186bopenalex-snapshot

Prediction of Multiple Binding Modes of the CDK2 Inhibitors, Anilinopyrazoles, Using the Automated Docking Programs GOLD, FlexX, and LigandFit: An Evaluation of Performance

inferred← citeshttps://doi.org/10.1021/ci600392ropenalex-snapshot

eHiTS-to-VMD Interface Application. The Search for Tyrosine−tRNA Ligase Inhibitors

inferred← citeshttps://doi.org/10.1021/ci800022eopenalex-snapshot

Evaluation of Virtual Screening Performance of Support Vector Machines Trained by Sparsely Distributed Active Compounds

inferred← citeshttps://doi.org/10.1021/ci800072ropenalex-snapshot

Virtual Screening Using PLS Discriminant Analysis and ROC Curve Approach: An Application Study on PDE4 Inhibitors

inferred← citeshttps://doi.org/10.1021/ci800174copenalex-snapshot

Approved Drug Mimics of Short Peptide Ligands from Protein Interaction Motifs

inferred← citeshttps://doi.org/10.1021/ci900135uopenalex-snapshot

Virtual Screening of Abl Inhibitors from Large Compound Libraries by Support Vector Machines

inferred← citeshttps://doi.org/10.1021/jm701275zopenalex-snapshot

Development of Potent and Selective Phosphinic Peptide Inhibitors of Angiotensin-Converting Enzyme 2

inferred← citeshttps://doi.org/10.1021/jm8005977openalex-snapshot

The Protein Data Bank (PDB), Its Related Services and Software Tools as Key Components for In Silico Guided Drug Discovery

inferred← citeshttps://doi.org/10.1021/jm900817uopenalex-snapshot

Three-Dimensional Pharmacophore Methods in Drug Discovery

inferred← citeshttps://doi.org/10.1039/9781847558879-00076openalex-snapshot

Pharmacophore-based Virtual Screening in Drug Discovery

inferred← citeshttps://doi.org/10.1039/c1md00210dopenalex-snapshot

From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling

inferred← citeshttps://doi.org/10.1039/c6ra01071gopenalex-snapshot

Molecular modeling of Plasmodium falciparum peptide deformylase and structure-based pharmacophore screening for inhibitors

inferred← citeshttps://doi.org/10.1042/bst0350561openalex-snapshot

New opportunities for protease ligand-binding site comparisons using SitesBase

inferred← citeshttps://doi.org/10.1042/cs20200476openalex-snapshot

Discovery and characterization of ACE2 – a 20-year journey of surprises from vasopeptidase to COVID-19

inferred← citeshttps://doi.org/10.1042/cs20200899openalex-snapshot

ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV

inferred← citeshttps://doi.org/10.1080/07391102.2019.1614094openalex-snapshot

Design of metronidazole derivatives and flavonoids as potential non-nucleoside reverse transcriptase inhibitors using combined ligand- and structure-based approaches

inferred← citeshttps://doi.org/10.1080/07391102.2019.1640794openalex-snapshot

Energetically optimized pharmacophore modeling to identify dual negative allosteric modulators against group I mGluRs in neurodegenerative diseases

inferred← citeshttps://doi.org/10.1080/08927022.2025.2574641openalex-snapshot

Computational insights into marine-derived pVHL-HIF1 α inhibitors: pharmacophore modelling, molecular docking, MD simulations, MM/PBSA and DFT studies

inferred← citeshttps://doi.org/10.1093/nar/gkab953openalex-snapshot

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents

inferred← citeshttps://doi.org/10.1111/cbdd.13344openalex-snapshot

3D‐quantitative structure‐activity relationship study for the design of novel enterovirus A71 3C protease inhibitors

inferred← citeshttps://doi.org/10.1111/j.1541-0420.2010.01460.xopenalex-snapshot

Hierarchical Bayesian Modeling of Pharmacophores in Bioinformatics

inferred← citeshttps://doi.org/10.1111/j.1742-4658.2008.06733.xopenalex-snapshot

Residues affecting the chloride regulation and substrate selectivity of the angiotensin‐converting enzymes (ACE and ACE2) identified by site‐directed mutagenesis

inferred← citeshttps://doi.org/10.1155/2012/307315openalex-snapshot

Angiotensin‐Converting Enzyme 2: The First Decade

inferred← citeshttps://doi.org/10.1155/2014/903246openalex-snapshot

Pharmacophore Modeling and Molecular Docking Studies on Pinus roxburghii as a Target for Diabetes Mellitus

inferred← citeshttps://doi.org/10.1161/circresaha.116.307708openalex-snapshot

Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure

inferred← citeshttps://doi.org/10.1186/1752-153x-6-139openalex-snapshot

Development and experimental test of support vector machines virtual screening method for searching Src inhibitors from large compound libraries

inferred← citeshttps://doi.org/10.1371/journal.pone.0121424openalex-snapshot

Structure- and Ligand-Based Virtual Screening Identifies New Scaffolds for Inhibitors of the Oncoprotein MDM2

inferred← citeshttps://doi.org/10.1371/journal.pone.0308913openalex-snapshot

Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations

inferred← citeshttps://doi.org/10.1504/ijbra.2013.056076openalex-snapshot

Receptor-based pharmacophore tool for design and development of next-generation drugs

inferred← citeshttps://doi.org/10.1515/chem-2023-0161openalex-snapshot

Utilization of computational methods for the identification of new natural inhibitors of human neutrophil elastase in inflammation therapy

inferred← citeshttps://doi.org/10.1515/dmdi-2012-0021openalex-snapshot

In silico pharmacology for a multidisciplinary drug discovery process

inferred← citeshttps://doi.org/10.1517/17460441.1.3.261openalex-snapshot

Pharmacophore modelling: applications in drug discovery

inferred← citeshttps://doi.org/10.18596/jotcsa.927426openalex-snapshot

Pharmacophore Modeling in Drug Discovery: Methodology and Current Status

inferred← citeshttps://doi.org/10.21203/rs.3.rs-640291/v1openalex-snapshot

Spike Protein Recognizer Receptor ACE2 Targeted Identification of Potential Natural Antiviral Drug Candidates Against SARS-CoV-2

inferred← citeshttps://doi.org/10.2147/jrlcr.s46845openalex-snapshot

Structure-based three-dimensional pharmacophores as an alternative to traditional methodologies

inferred← citeshttps://doi.org/10.2174/1568026619666181120142141openalex-snapshot

Application of Computational Techniques to Unravel Structure-Function Relationship and their Role in Therapeutic Development

inferred← citeshttps://doi.org/10.2174/1573407215666190131110930openalex-snapshot

3D Pharmacophore-based Ligand Alignment, Virtual Screening and Molecular Docking Protocols Towards the Discovery of 2-((1H-1,2,4-triazol-1- yl)methyl) Derivatives as Antifungal Inhibitors

inferred← citeshttps://doi.org/10.2217/14796678.4.2.175openalex-snapshot

Cardiovascular Protection by Angiotensin-Converting Enzyme 2: A New Paradigm

inferred← citeshttps://doi.org/10.22263/2312-4156.2021.1openalex-snapshot

inferred← citeshttps://doi.org/10.22263/2312-4156.2021.1.99openalex-snapshot

Chemical method for disposal of pharmaceutical waste of angiotensin-converting-enzyme inhibitor group

inferred← citeshttps://doi.org/10.2741/3788openalex-snapshot

Theoretical and computational approaches to ligand-based drug discovery

inferred← citeshttps://doi.org/10.3109/14756366.2016.1144593openalex-snapshot

Molecular dynamic simulations and structure-based pharmacophore development for farnesyltransferase inhibitors discovery

inferred← citeshttps://doi.org/10.3389/fchem.2022.986376openalex-snapshot

Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process

inferred← citeshttps://doi.org/10.3389/fchem.2024.1339891openalex-snapshot

Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies

inferred← citeshttps://doi.org/10.3389/fimmu.2020.552925openalex-snapshot

Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

inferred← citeshttps://doi.org/10.3390/ijms21218364openalex-snapshot

Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection

inferred← citeshttps://doi.org/10.3390/ph12010036openalex-snapshot

In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations

inferred← citeshttps://doi.org/10.3390/toxins17080371openalex-snapshot

Animal Venom in Modern Medicine: A Review of Therapeutic Applications

inferred← citeshttps://doi.org/10.4103/jcrt.jcrt_47_18openalex-snapshot

Ligand- and structure-based pharmacophore modeling, docking study reveals 2-[[4-[6-(isopropylamino) pyrimidin-4-yl]-1H-pyrrolo[2,3-b] pyridin-6-yl] amino] ethanol as a potential anticancer agent of CDK9/cyclin T1 kinase

inferred← citeshttps://doi.org/10.4103/jmss.jmss_66_20openalex-snapshot

Drug Repurposing Against Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Through Computational Approach

inferred← citeshttps://doi.org/10.5530/ijper.52.4.81openalex-snapshot

A Combination of Pharmacophore Modeling, Molecular Docking and Virtual Screening Study Reveals 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)- 4H-Chromen-4-One as a Potential Anti-Cancer Agent of COT Kinase

inferred← citeshttps://doi.org/10.5935/1984-6835.20120055openalex-snapshot

Virtual Screening Strategies in Drug Design

inferred← citeshttps://doi.org/10.7270/q2gt5pcbopenalex-snapshot

BindingDB Entry 50041537: Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite.

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.